Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:June 10, 2010Unknown status
Hide Studies Not Open or Pending
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:June 10, 2010Unknown status
Condition(s):Mitral Valve Regurgitation; Left Atrium Dilatation and Hypertrophy; Mitochondrial Dysfunction in the Heart; Cardiomyocyte Apoptosis; Cardiac InflammationLast Updated:September 10, 2013Unknown status
Condition(s):HypertriglyceridemiaLast Updated:February 8, 2016Withdrawn
Condition(s):Moderate Hypertriglyceridemia.Last Updated:February 25, 2013Unknown status
Condition(s):HypertriglyceridemiaLast Updated:October 20, 2021Completed
Condition(s):Coronary Artery DiseaseLast Updated:March 12, 2010Unknown status
Condition(s):HypertriglyceridemiaLast Updated:July 8, 2009Unknown status
Condition(s):High Triglycerides; Hypercholesterolemia; Schizophrenia; Schizoaffective Disorder; Bipolar DisorderLast Updated:July 2, 2017Completed
Condition(s):HypertriglyceridemiaLast Updated:January 25, 2011Completed
Condition(s):HypertriglyceridemiaLast Updated:October 9, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.